Strategy planning in coronary bifurcation stenting

Slides:



Advertisements
Similar presentations
Copyleft Clinical Trial Results. You Must Redistribute Slides PEPCAD II ISR Study Paclitaxel-eluting devices: randomized comparison of the SeQuent™ please.
Advertisements

A multicenter, randomized, prospective DKCRUSH-III study
BBC ONE David Hildick-Smith Sussex Cardiac Centre Brighton, UK on behalf of the BBC ONE Investigators.
Www. Clinical trial results.org  Major Endpoints: Death, MI, stent thrombosis, TLR, TVR, MACE, and CKMB >3x nl  Major Endpoints: Death, MI, stent thrombosis,
Bifurcation coronary stenting: State 0f the Art Mazhar M Khan Consultant Cardiologist Royal Victoria Hospital Belfast, N.Ireland.
BIFURCATION LESIONS Dr. Tahsin.N
Randomized Comparison of FFR-guided and Angiography-guided Provisional Stenting for True Coronary Bifurcation Lesions: The DKCRUSH-VI trial Shao-Liang.
29th ANNUAL SCIENTIFIC SESSIONS – SCA&I
Bifurcation Stenting: A primer
Tips and Pitfalls in Measurement of FFR during Bifurcation Stenting Nanjing first hospital Nanjing cardiovascular hospital Yefei Chenshaoliang Zhangjunjie.
Retrograde approach for the Recanalizaiton of Coronary CTO: Preliminary Experience of Single Centre Lei Ge, Juying Qian, Xuebo Liu, Qin Qing, Junbo Ge.
Trial Design Issues Associated with Evaluation of Distal Protection Devices in Diseased Saphenous Vein Grafts Bram D. Zuckerman, MD, FACC Medical Officer,
FRONTIER Registry The Guidant MULTI-LINK FRONTIER ™ Coronary Stent System for the Treatment of Pts with Native De Novo or Restenotic Bifurcation Coronary.
TCT 2012 Revascularization Strategies for Complex Left Main Disease and Left Coronary Ostial Disease Alfredo E. Rodriguez, MD, PhD, FACC, FSCAI Centro.
左主干分叉病变治疗策略的选择 Left main bifurcation: what is the best choice? Lei Ge, MD Department of Cardiology, Zhongshan Hospital, Fudan University.
LONG-TERM OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION FOR UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE: INITIAL CLINICAL EXPERIENCE. Graidis Ch. 1,
Side Branch Stenting Using Sirolimus-Eluting Stents in Bifurcation Lesions Trial Presented at The American College of Cardiology Scientific Session 2006.
Slow-rate release polymer-based paclitaxel- eluting stent compared with bare stent in patients with single complex coronary lesions TAXUS V Presented at.
A Prospective, Randomized Trial Evaluating a Paclitaxel-Eluting Balloon in Patients TReated with Endothelial Progenitor Cell CapTuring Stents for De Novo.
Direct Stenting is Better (Debate Session) 동아의대 김 무 현.
Treatment of bifurcation lesions is a complex problem Different techniques are commonly used (Y-/T-stenting, „culotte“ technique, „kissing stent“ technique…)
Lianglong Chen MD PhD FACC
Dedicated Bifurcation Stent Technology: Implications for Everyday Practice Jens Flensted Lassen MD, PH.D., FESC The Heart Centre, Rigshospitalet University.
Is there any role for intravascular ultrasound in bifurcation lesions? Giuseppe Biondi-Zoccai, MD University of Turin, Turin, Italy.
Date of download: 6/2/2016 Copyright © The American College of Cardiology. All rights reserved. From: Retrograde Techniques and the Impact of Operator.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Smoking Is Associated With Adverse Clinical Outcomes.
Ms. Leonardo Roever Coronary Stents. Coronary Artery Disease Leading cause of death in United States for men and women Caused by buildup of plaque in.
Date of download: 7/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: The FRONTIER Stent Registry: Safety and Feasibility.
Philippe Généreux, MD for the Tryton Bifurcation Trial Investigators Columbia University Medical Center Cardiovascular Research Foundation New York City.
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Severe Neointimal Hyperplasia of Neoplastic Carina.
Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Impact of Coronary Anatomy and Stenting Technique.
Intravascular ultrasound (IVUS) in percutaneous coronary intervention – summary of key articles While angiography is routinely used for assessment of CAD,
Bifurcation PCI: Basic Techniques and Data from Clinical Trials
The BVS-SAVE Italian registry: Bioresorbable Vascular Scaffolds
Bifurcation Management Update:
BRANCH Bare Metal BifuRcAtion SteNt Clinical Trial in Humans Early Clinical Experience by Raoul Bonan, MD On behalf of the BRANCH study investigators.
(DES)+BVS +DCB for long diffuse LAD disease
How to Handle a Complex Bifurcation Lesion
The Tryton Bifurcation Trial:
LONG-DES II Trial Randomized Comparison of the Efficacy of Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent in the Treatment of Long Native Coronary.
DKCRUSH V Shao-Liang Chen, MD DKCRUSH V
TAXUS IV Trial Slow-rate release polymer-based paclitaxel-eluting stent compared with bare stent in patients with single de novo coronary lesions Presented.
BVS Expand: First Results of Wide Clinical Applications
Subintimal Tracking and Reentry for CTO STAR Method
Stenting of Coronary Arteries in Non Stress/Benestent Disease
Impact of calcium on procedural and clinical outcomes in lesions treated with bioresorbable vascular scaffolds - A prospective BRS registry study  Jiang.
SKS Technique Clinical Case
The American College of Cardiology Presented by Dr. Maurits T. Dirksen
American College of Cardiology Presented by Dr. Stephan Windecker
REALITY: 8 month results
Incidence And Management Of Restenosis After Treatment Of Unprotected Left Main Disease With Drug-Eluting Stents: 70 Restenotic Cases From A Cohort Of.
Giuseppe Biondi Zoccai, MD
The American College of Cardiology Presented by Dr. Raimund Erbel
SIRIUS: A U.S. Multicenter, Randomized, Double-Blind Study of the SIRolImUS-Eluting Stent in De Novo Native Coronary Lesions Presented at TCT 2002.
Bifurcation Disease: Simulation Training Curriculum
Main branch restenosis at 1 year
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of.
TAXUS – Myonecrosis and sidebranch patency concerns are short-term issues with no long-term consequences, and the benefits are undeniable Jeffrey J. Popma,
Role of Stenting in Acute MI: PAMI Stent Pilot Trial
SMART-STRATEGY Trial design: Patients with a bifurcation coronary lesion were randomized to a conservative strategy (n = 128) vs. an aggressive strategy.
Presented at TCT 2006.
Martin B. Leon, David R. Holmes, Dean J. Kereiakes, Jeffrey J
Maintenance of Long-Term Clinical Benefit with
ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions J. Mehilli, MD Deutsches Herzzentrum Technische.
ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions J. Mehilli, MD Deutsches Herzzentrum Technische.
Sirolimus Stent vs. Bare Stent in Acute Myocardial Infarction Trial
APPROACH TO CORONARY BIFURCATION LESIONS
The American College of Cardiology Presented by Dr. A. Abazid
TYPHOON Trial Trial to Assess the Use of the Cypher Stent in Acute Myocardial Infarction Treated with Balloon Angioplasty (TYPHOON) Trial Presented at.
Tanveer Rab et al. JCIN 2017;10:
Presentation transcript:

Strategy planning in coronary bifurcation stenting IN THE NAME OF GOD Strategy planning in coronary bifurcation stenting OSTOVAN MD SHIRAZ medical School

Points and debates in bifurcation stenting Outcome : MACE ,stent thrombosis, TLR,… Wire protection in all cases? SB predilation? POT Significancy: Discrepancy between QCA and FFR. Selection of technique ,case based approach Preferred 2 stent technique? Modalities avoiding 2 stent strategy IVUS in bifurcation? BVS in bifurcation ?

Outcome

Wire protection in all cases? Chance of SB compromise is less when plaque burden is toward contralateral wall , or if its not a true bifurcation lesion. Protect from closure . Keeps SB open ,when dissection behind MB stent propagate into SB. You can see the site of SB take off ,so make recrossing easier with less contrast use . Modify the angle of take off ,so make it easier to recross. POT and high pressure inflation is safe with a jailed wire (nonhydrophilic wires).

SB predilation DON’T predidate the sidebranch ; even if very critically diseased, because you may face a SB dissection and and manipulating to Cross the wire into a dissected SB usually close it, if decide to do ,do it with a noncompliant balloon . Predilation effect usually vanishes after MB stenting

POT Optimise proximal MB Bows stent toward the SB , protect SB ostium from dissection and recoil . Makes wiring and balloon passage much easier. Limits risk of wiring under the stent struts POT and high pressure inflation is safe while keeping wire jailed (nonhydrophilic wires).

QCA and FFR Most of ostial compromise is due to geometric change , shift of carina and flow divider toward SB ostium ,so its not a true stenosis.

Kissing balloon If you decide to do a kiss : Recross by pulling back a j wire to cross distal cells (except in DK crush ).(slide 15) For difficult wire crossing : hydrophilic soft wire first , then more stronger like miracle …. Failure to cross the balloon to SB: 1- SB wire behind the MB struts ? 2- do POT 3- delicate CTO balloons with one marker 4-balloon anchoring technique 5- recross SB from another strut . Do kissing with noncompliant balloons . 2 step kissing is preferred.(slide 16) SMS technique when simultaneous kissing impossible . Balloon size 1:1 for SB and distal MB . Role of cutting , scoring balloon? Role of DEB for side branch patency?

Proximal vessel sizing

Techniques for 2 stenting T stenting variants : classical, provisional , modified , TAP . Crush technique variants : classic , minicrush , step crush , reversed (internal) minicrush , DK crush V stenting skirt technique SKS Culotte

Anatomical consideration in strategy planning Bifurcation angle and SB access difficulty Consider both Side branch size and length. Diffuseness of SB disease more than 6-10 mm from ostium . Emergency CASES (faster techniques) Discrepancy between MB and SB size . Which vessel to be treated first ?(take care of a gambling during your strategy selection!!!!) Your experience!!!

T stenting: angle more than 60-70 , simple , leave a Gap, TAP a good solution for all cases except very acute angle

Classic T

Classic T

TAP

Crush : a simple and rapid technique good for emergency situation, guaranty acute SB patency in cases with difficult SB access, but needs 7F guiding , 3 layer metal make final kiss difficult

Minicrush with final 2 step kiss

Minicrush with final 2 step kiss

D1 dissection after LAD predilation ,switch to DK crush

DK crush, final kissss

Culotte technique

V stenting for medina 0-1-1

SKS Technique : Very simple ,good for emergent cases like LMT Dissection ,good for 0-1-1 or even 1-1-1 when great discrepancy in size between prox MB and distal trunks and angle less than 90, neocarina ,excess metal , restenosis difficult to treat

6 month coronary angio SKS technique

For very big prox MB : SKS * For very big prox MB : SKS ** When SBA < 60 DK minicrush better than TAP

Tryton stent trial

Tips and tricks in difficulties

Tips and tricks in difficulties

Objectives The present study aimed to investigate the difference in major adverse cardiac events (MACE) at 12 months in patients with coronary bifurcation lesions after double kissing double crush (DK crush) or provisional stenting (PS) techniques. Background Provisional side branch (SB) stenting is preferable to DK crush because it has been associated with fewer complications. It is unknown which strategy would provide the best results. Methods From April 2007 to June 2009, 370 unselected patients with coronary bifurcation lesions from 7 Asian centers were randomly assigned to either the DK or the PS group. Additional SB stenting in PS was required if final results were suboptimal. The primary end point was the occurrence of MACE at 12 months, including cardiac death, myocardial infarction, or target vessel revascularization (TVR). Secondary end point was the angiographic restenosis at 8 months. Results There were 3 procedural occlusions of SB in the PS group. At 8 months, angiographic restenosis rates in the main vessel and SB were significantly different between the DK (3.8% and 4.9%) and the PS groups (9.7% and 22.2%, p = 0.036 and p < 0.001, respectively). Additional SB stenting in the PS group was required in 28.6% of lesions. TVR was 6.5% in the DK group, occurring significantly less often than in the PS group (14.6%, p = 0.017). There were nonsignificant differences in MACE and definite stent thrombosis between the DK (10.3% and 2.2%) and PS groups (17.3%, and 0.5%, p = 0.070 and p = 0.372, respectively). Conclusions DK crush was associated with a significant reduction of TLR and TVR in this unselected patient population. However, there was no significant difference in MACE between DK and the PS groups. (Randomized Study on DK Crush Technique Versus Provisional Stenting Technique for Coronary Artery Bifurcation Lesions; ChicTR-TRC-00000015)

Objectives The study aimed to investigate the difference in major adverse cardiac event (MACE) at 1-year after double kissing (DK) crush versus culotte stenting for unprotected left main coronary artery (UPLMCA) distal bifurcation lesions. Background DK crush and culotte stenting were reported to be effective for treatment of coronary bifurcation lesions. However, their comparative performance in UPLMCA bifurcation lesions is not known. Methods A total of 419 patients with UPLMCA bifurcation lesions were randomly assigned to DK (n ! 210) or culotte (n ! 209) treatment. The primary endpoint was the occurrence of a MACE at 1 year, including cardiac death, myocardial infarction, and target vessel revascularization (TVR). In-stent restenosis (ISR) at 8 months was secondary endpoint, and stent thrombosis (ST) served as a safety endpoint. Patients were stratified by SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) and NERS (New Risk Stratification) scores. Results Patients in the culotte group had significant higher 1-year MACE rate (16.3%), mainly driven by increased TVR (11.0%), compared with the DK group (6.2% and 4.3%, respectively; all p " 0.05). ISR rate in side branch was 12.6% in the culotte group and 6.8% in the DK group (p ! 0.037). Definite ST rate was 1.0% in the culotte group and 0% in the DK group (p ! 0.248). Among patients with bifurcation angle !70°, NERS score !20, and SYNTAX score !23, the 1-year MACE rate in the DK group (3.8%, 9.2%, and 7.1%, respectively) was significantly different to those in the culotte group(16.5%, 20.4%, and 18.9%, respectively; all p " 0.05). Conclusions Culotte stenting for UPLMCA bifurcation lesions was associated with significantly increased MACEs, mainly due to the increased TVR. (Double Kissing (DK) Crush Versus Culotte Stenting for the Treatment of Unprotected Distal Left Main Bifurcation Lesions: DKCRUSH-III, a Multicenter Randomized Study Comparing Double-Stent Techniques; ChiCTR-TRC-00000151) (J Am Coll Cardiol 2013;xx:xxx) © 2013 by the American College of Cardiology Foundation